Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Generalized fixed drug eruption suggesting potential association with dimenhydrinate: A rare case report

Jurnal kedokteran dan kesehatan Indonesia (2024) · hlm. 265–270

DOI
10.20885/jkki.vol15.iss2.art14
ISSN
2085-4145, 2527-2950
Terbit
2024-08-27
Penerbit
Islamic University of Indonesia
Bahasa
en
Lisensi
creativecommons.org/licenses/by/4.0/

Abstrak

Generalized fixed drug eruption (GFDE) is a specific variant of fixed drug eruption (FDE) characterized by multifocal lesions that recur upon exposure to a particular medication. This report describes a rare case of GFDE in a 54-year-old male, who presented with chief complaints of widespread erythema and pruritic, burning sensation. Physical examination revealed the patient to be in generally good condition dermatological status showed erosion on the hard palate, patches, erythematous macules, and partially ruptured bullae forming erosion in inguinal and genitals area, buttocks, thighs, lower legs, feet, axillae, hands, forearms, and back. The lesions were described as purplish round/oval erythematous patches, ranging from 1-4 cm in diameter, partially confluent, forming larger areas up to 6x7 cm, with bullae partially ruptured into erosion. The patient was admitted to the hospital, and treated with Ringer's lactate infusion, and an intravenous injection of 125 mg methylprednisolone. On the second day, the dose of intravenous methylprednisolone was reduced to 62.5 mg in the morning and the patient was administered a 10 mg cetirizine tablet orally in the evening, triamcinolone acetonide for oral lesions, a 15-minute NaCl 0.9% compress on the genitals twice a day, and desoximetasone 0.25% cream for all lesions. By the third day, the patient’s condition had improved, and he was then discharged. The prescribed home therapy regimen included a 16 mg methylprednisolone tablet in the morning, a 4 mg tablet in the afternoon, a 10 mg cetirizine tablet once daily, a 500 mg ciprofloxacin tablet twice daily, compress, and topical applications of triamcinolone acetonide for oral lesions and desoximetasone 0.25 % cream for all other lesions. A follow-up visit three days post-discharge indicated significant dermatological improvement. The diagnosis was established through anamnesis, physical examination, and appearance of skin disorder. Dimenhydrinate was identified as the potential causative agent.

Kata kunci

Jaringan kolaborasi para penulis

9 penulis · 16 tautan kepenulisan bersama · 3 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Islamic University of Indonesia
  • Universitas Gadjah Mada
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Rosmelia RosmeliaIslamic University of Indonesia2
Novyan LusiyanaIslamic University of Indonesia1
Onyxa KuspriyonoAfiliasi tidak diketahui1
Chaerul WidodoIslamic University of Indonesia1
Lamya Muthia NabilaIslamic University of Indonesia1
Yohanes Widodo WirohadidjojoUniversitas Gadjah Mada1
Hadi AnshoryIslamic University of Indonesia1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210214198, pertama di-harvest 20 Nov 2026, terakhir terlihat 20 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Generalized fixed drug eruption suggesting potential association with dimenhydrinate: A rare case report</dc:title><dc:creator>Betty Ekawati Suryaningsih</dc:creator><dc:creator>Trijanto Agoeng Noegroho</dc:creator><dc:subject>fixed drug eruption</dc:subject><dc:subject>dimenhydrinate</dc:subject><dc:subject>drug-induced skin reaction</dc:subject><dc:subject>drug hypersensitivity</dc:subject><dc:subject>bullous eruption</dc:subject><dc:subject>oral erosions</dc:subject><dc:subject>methylprednisolone</dc:subject><dc:subject>corticosteroid therapy</dc:subject><dc:subject>cetirizine</dc:subject><dc:subject>triamcinolone acetonide</dc:subject><dc:subject>desoximetasone</dc:subject><dc:subject>ciprofloxacin</dc:subject><dc:description xml:lang="en">Generalized fixed drug eruption (GFDE) is a specific variant of fixed drug eruption (FDE) characterized by multifocal lesions that recur upon exposure to a particular medication. This report describes a rare case of GFDE in a 54-year-old male, who presented with chief complaints of widespread erythema and pruritic, burning sensation. Physical examination revealed the patient to be in generally good condition dermatological status showed erosion on the hard palate, patches, erythematous macules, and partially ruptured bullae forming erosion in inguinal and genitals area, buttocks, thighs, lower legs, feet, axillae, hands, forearms, and back. The lesions were described as purplish round/oval erythematous patches, ranging from 1-4 cm in diameter, partially confluent, forming larger areas up to 6x7 cm, with bullae partially ruptured into erosion. The patient was admitted to the hospital, and treated with Ringer's lactate infusion, and an intravenous injection of 125 mg methylprednisolone. On the second day, the dose of intravenous methylprednisolone was reduced to 62.5 mg in the morning and the patient was administered a 10 mg cetirizine tablet orally in the evening, triamcinolone acetonide for oral lesions, a 15-minute NaCl 0.9% compress on the genitals twice a day, and desoximetasone 0.25% cream for all lesions. By the third day, the patient’s condition had improved, and he was then discharged. The prescribed home therapy regimen included a 16 mg methylprednisolone tablet in the morning, a 4 mg tablet in the afternoon, a 10 mg cetirizine tablet once daily, a 500 mg ciprofloxacin tablet twice daily, compress, and topical applications of triamcinolone acetonide for oral lesions and desoximetasone 0.25 % cream for all other lesions. A follow-up visit three days post-discharge indicated significant dermatological improvement. The diagnosis was established through anamnesis, physical examination, and appearance of skin disorder. Dimenhydrinate was identified as the potential causative agent.</dc:description><dc:publisher>Islamic University of Indonesia</dc:publisher><dc:date>2024-08-27</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>http://dx.doi.org/10.20885/jkki.vol15.iss2.art14</dc:identifier><dc:identifier>10.20885/jkki.vol15.iss2.art14</dc:identifier><dc:source>Jurnal kedokteran dan kesehatan Indonesia; (2024); 265-270</dc:source><dc:source>2085-4145</dc:source><dc:source>2527-2950</dc:source><dc:language>en</dc:language><dc:relation>https://journal.uii.ac.id/JKKI/article/download/31848/17126</dc:relation><dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights></oai_dc:dc>